<Disease><Name>APPARENT MINERALOCORTICOID EXCESS (AME)</Name><Synonym>11-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY, TYPE II; HSD11B2</Synonym><OMIM><Number>218030</Number><URL>http://omim.org/entry/218030</URL></OMIM><Orphanet><Number>320</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=320</URL></Orphanet><Protein><Number>Corticosteroid 11-beta-dehydrogenase isozyme 2</Number><URL>http://www.uniprot.org/uniprot/P80365</URL></Protein><ExPASy><Number>1.1.1.B40</Number><URL>http://enzyme.expasy.org/EC/1.1.1.B40</URL></ExPASy><Gene>16q22.1Detail information to gene locus by the National Center for Biotechnology Information NCBI:

Hydroxysteroid (11-beta) dehydrogenase 2
</Gene><ICD>E26.1</ICD><Summary>rare;autosomal recessive;mutation in the HSD11B2 gene</Summary><Symptoms><symtomp><id>2095</id><symptom>failure to thrive</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp><symtomp><id>1925</id><symptom>headache (severe, recurrent or occipital, migraine)</symptom><category>GENERAL TOPICS | HEAD</category></symtomp><symtomp><id>2296</id><symptom>hypertension</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>2066</id><symptom>metabolic alkalosis</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2109</id><symptom>short stature</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1700</id><symptom>small for gestational age (SGA), intrauterine growth retardation (IUGR)</symptom><category>GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>2139</id><name>Potassium</name><specimen>urine</specimen><value /><min>3.00</min><max>125.00</max><unit>mmol/24h</unit><age>ALL</age><method /><comment /></metabolite><metabolite><id>798</id><name>Aldosterone</name><specimen>plasma</specimen><value /><min>5.00</min><max>60.00</max><unit>ng/dl</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>799</id><name>Aldosterone</name><specimen>plasma</specimen><value /><min>1.00</min><max>160.00</max><unit>ng/dl</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>1407</id><name>Cortisol/cortisone ratio</name><specimen>urine</specimen><value /><min>0.00</min><max>1.00</max><unit>ratio</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>410</id><name>Potassium</name><specimen>serum</specimen><value>decreased</value><min>3.90</min><max>5.90</max><unit>mmol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>411</id><name>Potassium</name><specimen>serum</specimen><value>decreased</value><min>3.50</min><max>5.50</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>412</id><name>Potassium</name><specimen>serum</specimen><value>decreased</value><min>3.50</min><max>5.50</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>4742</id><title>Apparent mineralocorticoid excess</title><author>Funder JW</author><journal>J Steroid Biochem Mol Biol</journal><year>2017</year><book /><volume>165</volume><number>0</number><pages>151-153</pages><co_aut /></literature><literature><id>3218</id><title>Role of 11&#223;HSD type 2 enzyme activity in essential hypertension and children with chronic kidney disease (CKD)</title><author>Mongia A,</author><journal>J Clin Endocrinol Metab</journal><year>2012</year><book /><volume>97</volume><number>0</number><pages>3622-3629</pages><co_aut>et al.</co_aut></literature><literature><id>3220</id><title>Apparent mineralocorticoid excess syndrome: report of one family with three affected children</title><author>Al-Harbi T,</author><journal>J Pediatr Endocrinol Metab</journal><year>2012</year><book /><volume>25</volume><number>0</number><pages>1083-1088</pages><co_aut>Al-Shaikh A</co_aut></literature><literature><id>2687</id><title>11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action</title><author>Draper N</author><journal>J Endocrinol</journal><year>2005</year><book /><volume>186</volume><number>0</number><pages>251-271</pages><co_aut>Stewart PM</co_aut></literature><literature><id>2686</id><title>Apparent mineralocorticoid excess syndrome: an overview</title><author>Palermo M</author><journal>Arq Bras Endocrinol Metabol</journal><year>2004</year><book /><volume>48</volume><number>0</number><pages>687-696</pages><co_aut>Quinkler M, Stewart PM</co_aut></literature><literature><id>2688</id><title>A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol</title><author>Ulick S</author><journal>J Clin Endocrinol Metab</journal><year>1979</year><book /><volume>49</volume><number>5</number><pages>757-764</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>